Literatur
-
1
Gross W L.
Primär systemische Vaskulitiden Teil I: Allgemeine Übersicht.
Internist.
1999;
40
779-794
-
2
Landrin I, Chassagne P, Bouaniche M, Dominique S, Doucet J, Nouvet G, Bercoff E.
Pulmonary artery thrombosis in giant cell arteritis. A new case and review of literature.
Ann Med Interne (Paris).
1997;
148
315-316
-
3
Yamada I, Shibuya H, Matsubara H, Umehara I, Makino T, Numano F, Suzuki S.
Pulmonary artery disease in Takayasu arteritis: angiographic findings.
AJR.
1992;
159
263-269
-
4
Jennette J C, Falk R, Andrassy K, Bacon P A, Churg J, Gross W L, Hagen E C, Hoffman G S, Hunder G G, Kallenberg C GM, McCluskey R T, Sinico R A, Rees A J, van Es L A, Waldherr R, Wiik A.
Nomenclature of systemic vasculitis. Proposal of an International Consensus Conference.
Arthritis Rheum.
1994;
37
187-192
-
5
Abu-Shakra M, Smythe H, Lewtas J, Badley E, Weber D, Keystone E.
Outcome of polyarteritis nodosa and Churg-Strauss syndrome.
Arthritis Rheum.
1994;
37
1798-1803
-
6 King T E. Connective tissue disease. In: Schwartz, MI, King TEJ (eds) Interstitial lung disease (ed 2). St. Louis; Mosby Year Book 1993: 271-308
-
7
Gross W L.
Primär systemische Vaskulitiden Teil II: Krankheitsbild.
Internist.
1999;
40
951-968
-
8
Hunder G G, Arend W P, Bloch D A, Calabrese L H, Fauci A S, Fries J F, Leavitt R Y, Lie J T, Lightfoot R WJ, Masi A T.
The American College of Rheumatology 1990 criteria for the classification of vasculitis. Introduction.
Arthritis Rheum.
1990;
33
1085-1136
-
9
Gross W L.
Primär systemische Vaskulitiden Teil III: Pathogenese und Therapie.
Internist.
1999;
40
1194-1215
-
10
Gross W L.
New concepts in treatment protocols for severe systemic vasculitis.
Curr Op Rheumatol.
1999;
11
41-46
-
11
Schmitt W H, Paulsen J, Rudert H, Gross W L.
ANCA-assoziierte Vaskulitiden. Morbus Wegener, Mikroskopische Polyangiitis und Churg-Strauss-Syndrom.
HNO.
1997;
45
477-491
-
12
Hoffman G S, Kerr G S, Leavitt R Y, Hallahan C W, Lebovics R S, Travis W D, Rottem M, Fauci A S.
Wegener granulomatosis: an analysis of 158 patients.
Ann Intern Med.
1992;
116
488-498
-
13
DeRemee R A, McDonald T J, Weiland L H.
Aspekte zur Therapie und Verlaufsbeobachtungen der Wegenerschen Granulomatose.
Med Welt.
1987;
38
470-473
-
14
Schnabel A, Holl-Ullrich K, Dalhoff K, Reuter M, Gross W L.
Efficacy of transbronchial biopsy in pulmonary vasculitis.
Eur Respir J.
1997;
10
2738-2743
-
15
Muhle C, Reinhold-Keller E, Richter C, Beigel A, Brinkmann G, Gross W L, Heller M.
MRI of the nasal cavity, the paranasal sinuses and orbits in Wegener's granulomatosis.
Eur J Radiol.
1997;
7
566-570
-
16
Daum T E, Specks U, Colby T V, Edell E S, Brutinel M W, Prakash B S, DeRemee R A.
Tracheobronchial involvement in Wegener's granulomatosis.
Am J Respir Crit Care Med.
1995;
151
522-526
-
17
Csernok E, Trabandt A, Müller A, Wang G, Moosig F, Paulsen J, Schnabel A, Gross W L.
Cytokine profiles in Wegener's granulomatosis: predominance of type 1 (Th1) in the granulomatous inflammation.
Arthritis Rheum.
1992;
42
742-750
-
18
Stegemann C A, Cohen Tervaert J W, Sluiter W J, Manson W L, de Jong P E, Kallenberg C GM.
Association of chronic nasal carriage of Staphylococcus aureus and higher relapse rates in Wegener granulomatosis.
Ann Intern Med.
1994;
120
12-17
-
19
Jennette J C, Falk R J.
Pathogenesis of the vascular and glomerular damage in ANCA-positive vasculitis.
Nephrol Dial Transplant.
1998;
13 (Suppl. 1)
16-20
-
20
Csernok E, Müller A, Gross W L.
Immunopathology of ANCA-associated vasculitis.
Intern Med.
1999;
38
759-765
-
21
Brouwer E, Huitema M G, Mulder A HL, Heeringa P, van Goor H, Cohen Tervaert J W, Weening J J, Kallenberg C GM.
Neutrophil activation in vitro and in vivo in Wegener's granulomatosis.
Kidney Int.
1994;
45
1120-1131
-
22
Schnabel A, Csernok E, Braun J, Gross W L.
Activation of neutrophils, eosinophils and lymphocytes in the lower respiratory tract in Wegener's granulomatosis.
Am J Respir Crit Care Med.
1999;
in press
-
23
Baltaro R J, Hoffman G S, Sechsler J MG, Suffredini A F, Shelhamer J H, Fauci A S, Fleisher T A.
Immunoglobulin G antineutrophil cytoplasmic antibodies are produced in the respiratory tract of patients with Wegener's granulomatosis.
Am Rev Respir Dis.
1991;
143
275-278
-
24
Cordier J F, Valeyre D, Guillevin L, Loire R, Brechot J M.
Pulmonary Wegener's granulomatosis. A clinical and imaging study of 77 cases.
Chest.
1990;
97
906-912
-
25
Reuter M, Schnabel A, Wesner F, Tetzlaff K, Risheng Y, Gross W L, Heller M.
Pulmonary Wegener's granulomatosis. Correlation between high-resolution CT findings and clinical scoring disease activity.
Chest.
1998;
114
500-506
-
26
Travis W D, Hoffman G S, Leavitt R Y, Pass H I, Fauci A S.
Surgical pathology of the lung in Wegener's granulomatosis.
Am J Surg Pathol.
1991;
15
315-333
-
27
Barth J, Petermann W, Zemke F, Kreipe H, Gross W L.
Bronchoalveoläre Lavage bei Wegener'scher Granulomatose.
Pneumologie.
1991;
45
570-574
-
28
Schnabel A, Reuter M, Gloeckner K, Müller-Quernheim J, Gross W L.
Bronchoalveolar lavage cell profiles in Wegener's granulomatosis.
Respir Med.
1999;
93
498-506
-
29
Neild G H.
Infectious complications in the management of systemic vasculitis and rapidly progressive glomerulonephritis.
APMIS.
1999;
98 Suppl 19
56-60
-
30
Ognibene F P, Shelhamer J H, Hoffman G S, Kerr G S, Reda D, Fauci A S, Leavitt R Y.
Pneumocystis carinii pneumonia: a major complication of immunosuppressive therapy in patients with Wegener's granulomatosis.
Am J Resp Crit Care Med.
1995;
151
795-799
-
31
Haworth S J, Savage C OS, Carr D, Hughes J MB, Rees A J.
Pulmonary hemorrhage complicating Wegener's granulomatosis and microscopic polyarteritis.
Brit Med J.
1985;
290
1775-1778
-
32
ter Maaten J C, Franssen C FM, Gans R OB, Strack van Schindel R JM, Hoortje S J.
Respiratory failure in ANCA-associated vasculitis.
Chest.
1996;
110
347-362
-
33
Müller-Quernheim J, Dalhoff K, Schnabel A.
Immunsuppressive Therapie bei interstitiellen Lungenerkrankungen und immunologisch vermittelten Pneumonitiden.
Internist.
1997;
38
553-561
-
34
Langford C A, Sneller M C, Hallahan C W, Hoffman G S, Kammerer W A, Talar-Williams C, Fauci A S, Lebovics R S.
Clinical features and therapeutic management of subglottic stenosis in patients with Wegener's granulomatosis.
Arthritis Rheum.
1996;
39
1754-1760
-
35
Lebovics R S, Hoffman G S, Leavitt R Y, Kerr G S, Travis W D, Kammerer W, Hallahan C, Rottem M, Fauci A S.
The management of subglottic stenosis in patients with Wegener's granulomatosis.
Laryngoscope.
1992;
102
1341-1345
-
36
Screaton N J, Sivasothy P, Flower C DR, Lockwood C M.
Tracheal involvement in Wegener's granulomatosis: Evaluation using spiral CT.
Clin Radiol.
1998;
53
809-815
-
37
DeRemee R, Homburger H A, Specks U.
Lesions of the respiratory tract associated with the finding of anti-neutrophil cytoplasmic autoantibodies with a perinuclear staining pattern.
Mayo Clin Proc.
1994;
69
819-824
-
38
Guillevin L, Durand-Gasselin B, Cevallos R, Gayraud M, Lhote F, Callard P, Amouroux J, Casassus P, Jarrousse B.
Microscopic polyangiitis. Clinical and laboratory findings in eighty-five patients.
Arthritis Rheum.
1999;
42
421-430
-
39
Savage C OS, Winearls C G, Evans D J, Rees J, Lockwood C M.
Microscopic polyarteritis: Presentation, pathology and prognosis.
Q J Med.
1985;
56
467-483
-
40
Gaskin G, Savage C OS, Ryan J J, Jones S, Rees J, Lockwood C M, Pusey C D.
Antineutrophil cytoplasmic antibodies and disease activity during long-term follow-up of 70 patients with systemic vasculitis.
Nephrol Dial Transplant.
1991;
6
689-694
-
41
Jayne D RW, Marshall P D, Jones S J, Lockwood C M.
Autoantibodies to GBM and neutrophil cytoplasm in rapidly progressive glomerulonephritis.
Kidney Int.
1990;
37
965-970
-
42
Gross W L, Csernok E, Helmchen U.
Antineutrophil cytoplasmic autoantibodies, autoantigens, and systemic vasculitis.
APMIS.
1995;
103
81-97
-
43
Gaudin P B, Askin F B, Falk R J, Jennette J C.
The pathologic spectrum of pulmonary lesions in patients with anti-neutrophil cytoplasmic autoantibodies specific for anti-proteinase 3 and anti-myeloperoxidase.
Am J Clin Pathol.
1995;
104
7-16
-
44
Becker-Merok A, Nossent J C, Ritland N.
Fibrosing alveolitis predating microscopic polyangiitis.
Scand J Rheumatol.
1999;
28
254-256
-
45
Mistry N, Pusey C C, Gaskin G.
Markers of pulmonary haemorrhage in microscopic polyangiitis.
Sarcoidosis.
1996;
13
268
-
46
Lanham J G, Elkon K B, Pusey C D, Hughes G R.
Systemic vasculitis with asthma and eosinophilia: A clinical approach to the Churg-Strauss syndrome.
Medicine.
1984;
63
65-81
-
47
Guillevin L, Cohen P, Gayraud M, Lhote F, Jarrousse B, Casassus P.
Churg-Strauss syndrome: Clinical study and long-term follow-up of 96 patients.
Medicine.
1999;
78
26-37
-
48
Reid A JC, Harrison B DW, Watts R A, Watkin S W, McCann B G, Scott D GI.
Churg-Strauss syndrome in a district hospital.
Q J Med.
1998;
91
219-229
-
49
Lie J T.
Illustrated histopathologic classification criteria for selected vasculitis syndromes. American College of Rheumatology Subcommittee on Classification of Vasculitis.
Arthritis Rheum.
1990;
33
1074-1087
-
50
Fauci A S, Harley J B, Roberts W C, Ferrans V J, Gralnick H R, Bjornson B H.
The idiopathic hypereosinophilic syndrome.
Ann Intern Med.
1982;
97
78-92
-
51
Schnabel A, Csernok E, Braun J, Gross W L.
Inflammatory cells and cellular activation in the lower respiratory tract in Churg-Strauss syndrome.
Thorax.
1999;
54
771-778
-
52
Tatsis E, Schnabel A, Gross W L.
Interferon-alpha treatment of four patients with Churg-Strauss syndrome.
Ann Intern Med.
1998;
129
370-374
-
53
Stirling R G, Chung K F.
Leukotriene antagonists and Churg-Strauss syndrome: the smoking gun.
Thorax.
1999;
54
865-866
-
54
Green R J, Ruoss S J, Kraft S A, Berry G J, Raffin T A.
Pulmonary capillaritis and alveolar hemorrhage. Update on diagnosis and management.
Chest.
1996;
110
1305-1316
-
55
Schnabel A, Reuter M, Csernok E, Richter C, Gross W L.
Subclinical alveolar bleeding in pulmonary vasculitides - correlation with indices of disease activity.
Eur Respir J.
1999;
14
118-124
-
56
Bosch X, López-Soto A, Mirapeix E, Font J, Ingelmo M, Urbano-Márquez A.
Antineutrophil cytoplasmic autoantibody-associated alveolar capillaritis in patients presenting with pulmonary hemorrhage.
Arch Pathol Lab Med.
1994;
118
517-522
-
57
Lamprecht P, Schnabel A, Gross W L.
Hepatitis C-Virus assoziierte kryoglobulinämische Vaskulitis - Pathophysiologie, Diagnostik und Therapie.
Dtsch Med Wschr.
1998;
123
637-642
-
58
Manganelli P, Salaffi F, Subiaco S, Carott M, Cervini C, Consigli G, Majori M, Pesci A.
Bronchoalveolar lavage in mixed cryoglobulinaemia associated with hepatitis C virus.
Brit J Rheumatol.
1996;
35
978-982
-
59
Salaffi F, Manganelli P, Carotti M, Subiaco S, Cervini C.
Mixed cryoglobulinemia: effect of alpha-interferon on subclinical lymphocyte alveolitis.
Clin Exp Rheumatol.
1996;
14
219-220
-
60
Lamprecht P, Schmitt W H, Gross W L.
Mixed cryoglobulinemia, glomerulonephritis, and ANCA: Essential cryoglobulinemic vasculitis or ANCA-associated vasculitis.
Nephrol Dial Transplant.
1998;
13
213-221
-
61
Vats K R, Vats A, Kim Y, Dassenko D, Sinaiko A R.
Henoch-Schönlein purpura and pulmonary hemorrhage: a report and literature review.
Pediatr Nephrol.
1999;
13
530-534
-
62
Coppo R, Mazzucco G, Cagnoli L, Lupo A, Schena F P.
Long-term prognosis of Henoch-Schönlein nephritis in adults and children.
Nephrol Dial Transplant.
1997;
12
2277-2283
-
63
Kaklamani V, Vaiopoulos G, Kaklamanis P.
Behçet's disease.
Semin Arthritis Rheum.
1998;
27
197-217
-
64
International Study Group for Behçet's Disease .
Criteria for diagnosis of Behçet's disease.
Lancet.
1990;
335
1078-1080
-
65
Erkan F.
Pulmonary involvement in Behçet's disease.
Curr Opin Pulm Med.
1999;
5
314-318
-
66
DeLisser H M, Albelda S A.
The function of cell adhesion molecules in lung inflammation: More questions than answers.
Am J Respir Cell Mol Biol.
1998;
19
533-536
-
67
Mulligan M S, Vaporciyan A A, Warner R L, Jones M L, Foreman K E, Miyasaka M, Todd III R F, Ward P A.
Compartmentalized roles for leukocytic adhesion molecules in lung inflammatory injury.
J Immunol.
1995;
154
1350-1363
Dr. PD A. Schnabel
Poliklinik für Rheumatologie Universität Lübeck
Ratzeburger Allee 160
23538 Lübeck
